Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241305 · ClinicalTrials.gov registry record
One-Time DNA Study for Vasculitis
A clinical trial of Giant Cell Arteritis and Microscopic Polyangiitis, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 14
- Study locations
NCT01241305: Recruiting study of Giant Cell Arteritis and Microscopic Polyangiitis, sponsored by University of Pennsylvania.
NCT01241305 is a study of Giant Cell Arteritis and Microscopic Polyangiitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher). The trial reports 14 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01241305, a study of Giant Cell Arteritis and Microscopic Polyangiitis, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Conditions Studied
Study Locations (14)
California
- Cedars-Sinai Medical Center - Los Angeles
- University of California, San Francisco - San Francisco
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Ontario
- St. Joseph's Healthcare - Hamilton
- Mount Sinai Hospital - Toronto
Illinois
- Northwestern University - Chicago
Kansas
- University of Kansas Medical Center - Kansas City
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic - Rochester
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-10 |
| Est. Completion | 2028-08 |
What NCT01241305 shows while recruiting
NCT01241305 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher).
The record links to 6 conditions, with Giant Cell Arteritis appearing as the primary indexed condition, and to 0 interventions.
NCT01241305 lists 14 locations in 11 states (California, Pennsylvania, Ontario).
Frequently Asked Questions
What is clinical trial NCT01241305 about?
NCT01241305 is a clinical study titled "One-Time DNA Study for Vasculitis". The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas fo...
What is the current status of trial NCT01241305?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2010-10. Estimated completion is 2028-08.
What conditions does trial NCT01241305 study?
This clinical trial studies the following conditions: Giant Cell Arteritis, Microscopic Polyangiitis, Takayasu's Arteritis, Polyarteritis Nodosa, Granulomatosis With Polyangiitis (Wegener's).
Who is sponsoring clinical trial NCT01241305?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01241305 being conducted?
This trial has 14 study locations across California, Illinois, Kansas, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Giant Cell Arteritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
RECRUITING
-
VCRC Tissue Repository
RECRUITING
-
Abatacept for the Treatment of Giant Cell Arteritis
RECRUITING · Phase 3
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
RECRUITING
-
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
COMPLETED · Phase 2
-
Vasculitis Illness Perception (VIP) Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia